About Noninvasix
Noninvasix is a company based in Galveston (United States) founded in 2007.. Noninvasix has raised $5.95 million across 11 funding rounds from investors including Philips, HHS and Texas Medical Center. Noninvasix offers products and services including Optoacoustic Platform. Noninvasix operates in a competitive market with competitors including kegg, Raydiant Oximetry, Femometer, HeraMED and OBMedical, among others.
- Headquarter Galveston, United States
-
Sectors
ConsumerHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Noninvasix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.95 M (USD)
in 11 rounds
-
Latest Funding Round
$2 M (USD), Seed
Jan 04, 2021
-
Investors
Philips
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Noninvasix
Noninvasix offers a comprehensive portfolio of products and services, including Optoacoustic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive system for real-time sepsis and tissue hypoxia measurement.
Unlock access to complete
Unlock access to complete
Funding Insights of Noninvasix
Noninvasix has successfully raised a total of $5.95M across 11 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Seed — $2.0M
-
First Round
First Round
(21 Jul 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Seed - Noninvasix | Valuation | TMC Venture Fund | |
| Jun, 2020 | Amount | Seed - Noninvasix | Valuation |
investors |
|
| Jan, 2019 | Amount | Seed - Noninvasix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Noninvasix
Noninvasix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Philips, HHS and Texas Medical Center. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage Life-Sciences & Offline focused VC firm funding companies in the US
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made in medical startups.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in health and life sciences sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Noninvasix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Noninvasix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Noninvasix Comparisons
Competitors of Noninvasix
Noninvasix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as kegg, Raydiant Oximetry, Femometer, HeraMED and OBMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fertility tracking and pelvic health solutions are provided by kegg.
|
|
| domain | founded_year | HQ Location |
Wearable device for non-invasive fetal blood oxygen monitoring is offered.
|
|
| domain | founded_year | HQ Location |
Basal body temperature is tracked by Femometer for cycle monitoring.
|
|
| domain | founded_year | HQ Location |
Smartphone-based devices for pregnancy monitoring are provided.
|
|
| domain | founded_year | HQ Location |
Fetal heart rate and contractions are monitored via wireless electrodes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Noninvasix
Frequently Asked Questions about Noninvasix
When was Noninvasix founded?
Noninvasix was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Noninvasix located?
Noninvasix is headquartered in Galveston, United States. It is registered at Galveston, Texas, United States.
Who is the current CEO of Noninvasix?
David Giarracco is the current CEO of Noninvasix.
Is Noninvasix a funded company?
Noninvasix is a funded company, having raised a total of $5.95M across 11 funding rounds to date.
What does Noninvasix do?
Developer of a fetal blood oxygenation monitoring device. It uses laser optics to measure acoustic patterns, generating an accurate snapshot of oxygenation levels, size, and location of blood vessels for fetal monitoring. It involves a tiny probe, inserted transvaginally, and sends near-infrared light rays into the brains superior sagittal sinus vein. It causes rapid thermal expansion of the hemoglobin resulting in a measurable acoustic wave which is analyzed by software.
Who are the top competitors of Noninvasix?
Noninvasix's top competitors include kegg, HeraMED and Raydiant Oximetry.
What products or services does Noninvasix offer?
Noninvasix offers Optoacoustic Platform.
Who are Noninvasix's investors?
Noninvasix has 5 investors. Key investors include Philips, HHS, Texas Medical Center, TMC Venture Fund, and Green Park & Golf Ventures.